Suppr超能文献

生长分化因子 15 的表达在因志愿献血而导致缺铁的个体中并未升高。

Expression of growth differentiation factor 15 is not elevated in individuals with iron deficiency secondary to volunteer blood donation.

机构信息

Molecular Medicine Branch, NIDDK, Department of Transfusion Medicine, NIH, Bethesda, Maryland 20892, USA.

出版信息

Transfusion. 2010 Jul;50(7):1532-5. doi: 10.1111/j.1537-2995.2010.02601.x. Epub 2010 Feb 26.

Abstract

BACKGROUND

Low serum hepcidin levels provide a physiologic response to iron demand in patients with iron deficiency (ID). Based on a discovery of suppressed hepcidin expression by a cytokine named growth differentiation factor 15 (GDF15), it was hypothesized that GDF15 may suppress hepcidin expression in humans with ID due to blood loss.

STUDY DESIGN AND METHODS

To test this hypothesis, GDF15 and hepcidin levels were measured in peripheral blood from subjects with iron-deficient erythropoiesis before and after iron supplementation.

RESULTS

Iron variables and hepcidin levels were significantly suppressed in iron-deficient blood donors compared to healthy volunteers. However, ID was not associated with elevated serum levels of GDF15. Instead, iron-deficient subjects' GDF15 levels were slightly lower than those measured in the control group of subjects (307 +/- 90 and 386 +/- 104 pg/mL, respectively). Additionally, GDF15 levels were not significantly altered by iron repletion.

CONCLUSIONS

ID due to blood loss is not associated with a significant change in serum levels of GDF15.

摘要

背景

低血清铁调素水平为缺铁(ID)患者对铁需求提供了生理反应。基于细胞因子命名为生长分化因子 15(GDF15)抑制铁调素表达的发现,假设 GDF15 可能由于失血而抑制 ID 患者的铁调素表达。

研究设计与方法

为了验证这一假设,在铁补充前后测量了缺铁性红细胞生成患者外周血中的 GDF15 和铁调素水平。

结果

与健康志愿者相比,缺铁性献血者的铁变量和铁调素水平显著降低。然而,ID 与血清 GDF15 水平升高无关。相反,缺铁患者的 GDF15 水平略低于对照组患者(分别为 307±90 和 386±104pg/ml)。此外,铁补充并没有显著改变 GDF15 水平。

结论

失血引起的 ID 与血清 GDF15 水平的显著变化无关。

相似文献

1
Expression of growth differentiation factor 15 is not elevated in individuals with iron deficiency secondary to volunteer blood donation.
Transfusion. 2010 Jul;50(7):1532-5. doi: 10.1111/j.1537-2995.2010.02601.x. Epub 2010 Feb 26.
2
Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I.
Blood. 2008 Dec 15;112(13):5241-4. doi: 10.1182/blood-2008-06-165738. Epub 2008 Sep 29.
4
Iron Status in Newly Diagnosed -Thalassemia Major: High Rate of Iron Status due to Erythropoiesis Drive.
Biomed Res Int. 2021 Apr 16;2021:5560319. doi: 10.1155/2021/5560319. eCollection 2021.
5
High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin.
Nat Med. 2007 Sep;13(9):1096-101. doi: 10.1038/nm1629. Epub 2007 Aug 26.
6
Regulation of iron metabolism through GDF15 and hepcidin in pyruvate kinase deficiency.
Br J Haematol. 2009 Mar;144(5):789-93. doi: 10.1111/j.1365-2141.2008.07535.x. Epub 2008 Dec 20.
7
Hepcidin is correlated to soluble hemojuvelin but not to increased GDF15 during pregnancy.
Blood Cells Mol Dis. 2012 Apr 15;48(4):233-7. doi: 10.1016/j.bcmd.2012.02.001. Epub 2012 Feb 25.
8
The association between growth differentiation factor-15, erythroferrone, and iron status in thalassemic patients.
Pediatr Res. 2024 Mar;95(4):1095-1100. doi: 10.1038/s41390-023-02729-5. Epub 2023 Jul 18.
9
Growth differentiation factor 15 in patients with congenital dyserythropoietic anaemia (CDA) type II.
J Mol Med (Berl). 2011 Aug;89(8):811-6. doi: 10.1007/s00109-011-0751-5. Epub 2011 Apr 8.
10
Growth differentiation factor 15 in anaemia of chronic disease, iron deficiency anaemia and mixed type anaemia.
Br J Haematol. 2010 Feb;148(3):449-55. doi: 10.1111/j.1365-2141.2009.07961.x. Epub 2009 Oct 15.

引用本文的文献

1
GDF-15 and hepcidin as a therapeutic target for anemia in chronic kidney disease.
Ital J Pediatr. 2023 Aug 30;49(1):106. doi: 10.1186/s13052-023-01505-9.
5
Smad1/5 is required for erythropoietin-mediated suppression of hepcidin in mice.
Blood. 2017 Jul 6;130(1):73-83. doi: 10.1182/blood-2016-12-759423. Epub 2017 Apr 24.
6
Decreasing TfR1 expression reverses anemia and hepcidin suppression in β-thalassemic mice.
Blood. 2017 Mar 16;129(11):1514-1526. doi: 10.1182/blood-2016-09-742387. Epub 2017 Feb 1.
7
Hepcidin/Ferritin Quotient Helps to Predict Spontaneous Recovery from Iron Loss following Blood Donation.
Transfus Med Hemother. 2015 Nov;42(6):390-5. doi: 10.1159/000440825. Epub 2015 Nov 3.
8
Iron chelation therapy in transfusion-dependent thalassemia patients: current strategies and future directions.
J Blood Med. 2015 Jun 17;6:197-209. doi: 10.2147/JBM.S72463. eCollection 2015.
9
Evidence that the expression of transferrin receptor 1 on erythroid marrow cells mediates hepcidin suppression in the liver.
Exp Hematol. 2015 Jun;43(6):469-78.e6. doi: 10.1016/j.exphem.2015.03.001. Epub 2015 Mar 14.
10
New insights into iron regulation and erythropoiesis.
Curr Opin Hematol. 2015 May;22(3):199-205. doi: 10.1097/MOH.0000000000000132.

本文引用的文献

1
Regulation of growth differentiation factor 15 expression by intracellular iron.
Blood. 2009 Feb 12;113(7):1555-63. doi: 10.1182/blood-2008-07-170431. Epub 2008 Dec 1.
2
Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I.
Blood. 2008 Dec 15;112(13):5241-4. doi: 10.1182/blood-2008-06-165738. Epub 2008 Sep 29.
3
Immunoassay for human serum hepcidin.
Blood. 2008 Nov 15;112(10):4292-7. doi: 10.1182/blood-2008-02-139915. Epub 2008 Aug 8.
4
Behavioral, biochemical, and genetic analysis of iron metabolism in high-intensity blood donors.
Transfusion. 2008 Oct;48(10):2197-204. doi: 10.1111/j.1537-2995.2008.01823.x. Epub 2008 Jul 24.
5
Iron regulation and erythropoiesis.
Curr Opin Hematol. 2008 May;15(3):169-75. doi: 10.1097/MOH.0b013e3282f73335.
6
Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBPalpha.
Blood. 2008 Jun 15;111(12):5727-33. doi: 10.1182/blood-2007-08-106195. Epub 2008 Mar 7.
7
High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin.
Nat Med. 2007 Sep;13(9):1096-101. doi: 10.1038/nm1629. Epub 2007 Aug 26.
8
A p53-type response element in the GDF15 promoter confers high specificity for p53 activation.
Biochem Biophys Res Commun. 2007 Mar 23;354(4):913-8. doi: 10.1016/j.bbrc.2007.01.089. Epub 2007 Jan 25.
9
Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications.
Clin Chem. 2007 Apr;53(4):620-8. doi: 10.1373/clinchem.2006.079186. Epub 2007 Feb 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验